148 results on '"Kurtoglu, Metin"'
Search Results
2. Performance of a moment resisting beam-column connection for precast concrete construction
3. Twelve-Month Follow-Up of Patients With Generalized Myasthenia Gravis Receiving BCMA-Directed mRNA Cell Therapy
4. Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
5. Driving the expansion of mRNA into the therapeutic sphere
6. Supplementary Fig. S1 from Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines
7. Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma
8. Unleashing the full potential of cell therapy through RNA engineering
9. Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1–expressing myeloma cells
10. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
11. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-d-glucose
12. Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow
13. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells
14. A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
15. 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
16. AuNP-DG: Deoxyglucose-Labeled Gold Nanoparticles as X-ray Computed Tomography Contrast Agents for Cancer Imaging
17. High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors
18. Efficacy of 2-halogen substituted d-glucose analogs in blocking glycolysis and killing “hypoxic tumor cells”
19. Global variability of the human IgG glycome
20. Global variability of the human IgG glycome
21. Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
22. From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors
23. Engineering human stellate cells for beta cell replacement therapy promotes in vivo recruitment of regulatory T cells
24. Preclinical Evaluation of CD8+ Anti-Bcma mRNA CAR T-Cells for the Control of Human Multiple Myeloma
25. Preclinical evaluation of CD8+ Anti-BCMA mRNA CAR T-Cells for control of multiple myeloma
26. Global variability of the human IgG glycome
27. Obstructive pancreatitis is a stronger fibrogenic stimulus than cancer-specific stellate cell activation in pancreatic ductal adenocarcinoma
28. Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress
29. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
30. Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades
31. Intrinsically lower AKT, mTOR and HIF activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines
32. CD8+ Anti-BCMA mRNA CAR T-Cells Effectively Kill Human Multiple Myeloma Cells In Vitro and In Vivo
33. Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)
34. The wonders of 2-deoxy-d-glucose
35. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
36. Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-d-glucose
37. Getting It Off Her Chest: A Case of an Anterior Mediastinal Mass
38. The role of hypoxia in pancreatic cancer: a potential therapeutic target?
39. A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
40. Activation of the Unfolded Protein Response by 2-Deoxy- d -Glucose Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication and Gene Expression
41. Abstract 4064: Overcoming resistance to 2-deoxy-glucose and glucose deprivation in tumor cells under normoxia by modulating the unfolded protein response
42. Abstract 4087: Metabolic changes associated with acquired cisplatin resistance
43. Abstract 2725: 2-Deoxyglucose inhibits KSHV replication under normoxic conditions
44. Distribution of Bim Determines MCL-1 Dependence or Co-Dependence on BCL-xL/BCL-2 In Multiple Myeloma
45. Antiangiogenic Activity of 2-Deoxy-D-Glucose
46. A novel functional CT contrast agent for molecular imaging of cancer
47. 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
48. Abstract 4840: 2-Deoxy-D-glucose induces autophagy through endoplasmic reticulum stress rather than by lowering ATP
49. Displacement of Bim From Anti-Apoptotic Proteins Is the Primary Factor for Determining ABT-737 Activity in Multiple Myeloma Cell Lines.
50. GHRH antagonist causes DNA damage leading to p21 mediated cell cycle arrest and apoptosis in human colon cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.